TORIPALIMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where TORIPALIMAB was used for Prostate cancer.
Most Reported Side Effects for TORIPALIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 590 | 43.9% | 3 | 432 |
| Off label use | 276 | 20.5% | 29 | 137 |
| White blood cell count decreased | 144 | 10.7% | 0 | 74 |
| Anaemia | 67 | 5.0% | 17 | 8 |
| Hypothyroidism | 67 | 5.0% | 13 | 11 |
| Neutrophil count decreased | 67 | 5.0% | 0 | 25 |
| Nausea | 60 | 4.5% | 7 | 14 |
| Rash | 59 | 4.4% | 7 | 11 |
| Vomiting | 58 | 4.3% | 7 | 14 |
| Platelet count decreased | 53 | 3.9% | 3 | 30 |
| Diarrhoea | 50 | 3.7% | 6 | 16 |
| Neutropenia | 49 | 3.7% | 8 | 1 |
| Thrombocytopenia | 48 | 3.6% | 12 | 0 |
| Pyrexia | 46 | 3.4% | 2 | 13 |
| Decreased appetite | 43 | 3.2% | 9 | 9 |
Other Indications for TORIPALIMAB
Nasopharyngeal cancer (163)
Hepatocellular carcinoma (125)
Oesophageal carcinoma (72)
Lung neoplasm malignant (65)
Breast cancer (40)
Malignant melanoma (36)
Small cell lung cancer (36)
Hepatic cancer (34)
Renal cancer (34)
Bladder cancer (33)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)